Prognostic value of matrix metalloproteinase 9 expression in patients with non-small cell lung cancer
Authors:
- Jun-Qing ZhangJZJun-Qing Zhang
- Bing-Xiang WangBWBing-Xiang Wang
- Hai-Feng PanHPHai-Feng Pan
- Man-Man LuMLMan-Man Lu
- Jing WangJWJing Wang
- 1 July 2012
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 413 (13-14) , 1121-1126
Abstract
No abstract availableKeywords
Funding Information
- Academic Leader Foundation of Anhui Medical University
- Key Project of the Education Department of Anhui Province Natural Science Research (KJ2012A165)
This publication has 31 references indexed in Scilit:
- High p27 expression is associated with a better prognosis in East Asian non-small cell lung cancer patientsClinica Chimica Acta, 2011
- Lung Cancer: Are we up to the Challenge?Current Genomics, 2010
- The Role of Matrix Metalloproteinase 2 on the Survival of Patients with Non-Small Cell Lung Cancer: A Systematic Review with Meta-AnalysisCancer Investigation, 2009
- Epidemiology of Lung CancerChest, 2007
- The significance of serum active matrix metalloproteinase-9 in patients with non-small cell lung cancerLung Cancer, 2004
- Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysisBritish Journal of Cancer, 2003
- Prognostic impact of Cathepsin B and matrix metalloproteinase-9 in pulmonary adenocarcinomas by immunohistochemical studyLung Cancer, 2000
- Plasma assay of gelatinase B:Tissue inhibitor of metalloproteinase complexes in cancerCancer, 1995
- Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party.Journal of Clinical Oncology, 1995
- A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomasNature, 1990